Scarica l'app Stockscreener
0.206
9.69%
-0.0221
Dopo l'orario di chiusura:
.20
-0.006
-2.91%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Cosmos Health Inc Borsa (COSM) Ultime notizie
Cosmos Health Inc. Announces Proposed Acquisition of Doc Pharma S.A. to Enhance Vertical Integration and Product Portfolio - Quiver Quantitative
Cosmos Health pursues Doc Pharma deal, adding $6.7M in sales - Stock Titan
Cosmos Health Secures Additional 180-Day Nasdaq Extension To Regain Bid Price Compliance - TradingView
Cosmos Health gets Nasdaq extension to regain $1 minimum bid price - Investing.com
Cosmos Health gets Dec. 7 deadline from Nasdaq; reverse split only last resort - Stock Titan
Cosmos Health CEO addresses shareholders amid stock decline - Investing.com UK
Cosmos Health targets $200M revenue by 2029, driven by U.S. expansion - scanx.trade
$20 Million in Liquid Assets Support Rapid Growth Including Acquisitions, Bio Pharma Production and Nanotechnology Initiatives for Diversified Global Heath Leader Cosmos Health, Inc. (Nasdaq: COSM) - Barchart.com
Cosmos Health (COSM) Secures Manufacturing Deal with Verisfield S.A. - GuruFocus
Cosmos Health subsidiary secures manufacturing deal By Investing.com - Investing.com Australia
Cosmos Health subsidiary secures manufacturing deal - Investing.com
Cosmos Health Inc. - Via Ritzau
Cosmos Health CEO addresses shareholders amid stock decline By Investing.com - Investing.com Nigeria
Cosmos Health CEO Issues Letter to Shareholders: Building - GlobeNewswire
Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway | FinancialContent - FinancialContent
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com UK
Cosmos Health (COSM) Launches New Capsule Production and Signs C - GuruFocus
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Inc. Subsidiary Cana Laboratories Inaugurates New Capsule Production Line and Secures Contract with Provident Pharmaceuticals - Quiver Quantitative
Factory upgrade backs 385,000-dose antidepressant deal contract - Stock Titan
Cosmos Health (COSM) Expands Innovation with Patent Acquisition - GuruFocus
Cosmos Health subsidiary acquires nanotechnology patent By Investing.com - Investing.com Australia
Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives - The Manila Times
Cosmos Health subsidiary acquires nanotechnology patent - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Acquires International Patent to Enhance Nanotechnology Investment Initiatives - Quiver Quantitative
Cosmos Health Completes Acquisition of Strategic - GlobeNewswire
New nanotech patent backs Cosmos Health’s next-gen pharma plans - Stock Titan
Andreas Bovopoulos holds 4.32M Cosmos Health (COSM) shares — Schedule 13G/A - Stock Titan
Cosmos Health Inc.: Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - FinanzNachrichten.de
Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories - The Manila Times
New Oliv18 capsule packs 11 tsp of olive oil for heart support - Stock Titan
Key facts: Cosmos Health may monetize ~$15M assets; lists 96 products EU - TradingView
Cosmos Health Inc. (NASDAQ: COSM) $200M shelf; discloses crypto treasury strategy - Stock Titan
Cosmos Health expands Sky Premium Life to all 27 EU states - Investing.com UK
Cosmos Health launches Fort18 men’s wellness supplement in U.S. - Investing.com
$65.3 Million Revenue in 2025 Followed by Q1 2026 Record of $17.9 Million with Momentum Continuing in Q2 for Diversified Global Heath Leader Cosmos Health Inc. (Nasdaq: COSM) - Barchart.com
Cosmos Health expands Sky Premium Life to all 27 EU states By Investing.com - Investing.com South Africa
Vitamins brand Sky Premium Life goes on sale in all 27 EU countries - Stock Titan
Cosmos Health (COSM) to Explore Monetization of Non-Core Assets - GuruFocus
Cosmos Health explores sale of non-core assets worth $20M By Investing.com - Investing.com India
Cosmos Health explores sale of non-core assets worth $20M - Investing.com Nigeria
Cosmos Health Identifies Approximately $20 Million in - GlobeNewswire
Cosmos Health Inc. Identifies $20 Million in Non-Core Assets for Potential Monetization - Moomoo
Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value - The Globe and Mail
Cosmos Health Bets the Farm—Literally—on a $20 Million Revival Plan - BriefGlance
Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029 - WBOC TV
Cosmos Health (NASDAQ: COSM) outlines 2026 proxy, 10M-share equity plan and Series B preferred - Stock Titan
Cosmos Health reports balance sheet improvements, EIB talks By Investing.com - Investing.com South Africa
Cosmos Health reports balance sheet improvements, EIB talks - Investing.com
Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang with No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent S - The Manila Times
Cosmos Health trims $4.5M debt, weighs €25M EIB deal, drops 38% warrants - Stock Titan
0.22%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):